Operative indication for functional tricuspid regurgitation (TR) remains controversial.
According to the guidelines, it is determined based on severity of TR, symptoms, annular
diameter, pulmonary hypertension and right ventricular (RV) function. However, there
are many problems in the guidelines, such as difficulties in determining symptoms,
quantification of TR severity and evaluation of RV function. There are many echocardiographic
parameters of RV function, but any of them have not been established. Surgical treatment
for functional TR is classified into two patterns; one is tricuspid annuloplasty concomitant
with mitral valve surgery and the other is “isolated” tricuspid valve surgery. We
should consider them as different disease entities because they show totally different
clinical characteristics and prognosis. RV function is critical especially in isolated
tricuspid valve surgery. In clinical settings, “isolated” tricuspid valve surgery
has not been enough performed. Poor outcomes of “isolated” tricuspid valve surgery
has been related to our reluctance to perform tricuspid surgery. There have been controversial
issues in operative indication and its optimal timing and selection of operative procedures
in patients with “isolated” TR. I would like to discuss these issues based on previous
studies and our experience in the real world of our daily practice.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiac FailureAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect